Is immortality achievable? With longevity science booming, you might make it to age 150 — but your portfolio might not.

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

China's commitment to foster innovation and advance high-standard opening-up has provided global pharmaceutical companies ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

Alnylam Pharmaceuticals gains FDA approval for Amvuttra in ATTR-CM, boosting revenue prospects. Click here to read an ...

Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has approved an amendment to its previously disclosed limited duration ...

AstraZeneca has announced a $2.5 billion investment in a research and development hub in Beijing, underscoring its commitment ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a ...

Executives share insight into whether the tremendous market growth in LATAM is scalable for the biologicals industry.

However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...